PortViewPortView
Renovacor logo

Renovacor (RCOR) Stock Analysis

AMEXHealthcareBiotechnology

$3.20+4.92%
1-year price historyRange $1.56 – $9.39
52-week range$3.20
$1.34$9.01

What Renovacor does

Renovacor is a biotechnology firm dedicated to developing targeted treatments aimed at improving the lives of individuals and families grappling with genetically-driven cardiovascular diseases and other related conditions. Its primary therapeutic focus is on dilated cardiomyopathy (DCM) linked to mutations in the BCL2-associated athanogene 3 (BAG3) gene. The company's flagship product candidate, REN-001, is a sophisticated gene therapy employing a recombinant adeno-associated virus 9. This treatment is engineered to deliver a healthy BAG3 gene into heart muscle cells (cardiomyocytes) to boost BAG3 protein levels, with the ultimate objective of slowing down or halting the progression of BAG3-associated DCM. Beyond its lead candidate, Renovacor is also advancing a pipeline of additional BAG3-focused gene therapies. These initiatives aim to address a range of diseases characterized by significant unmet medical needs, which are associated with BAG3 gene mutations and intrinsically linked to the protein's expression and function. Founded in 2013, the company's operations are based in Greenwich, Connecticut.

Key metrics

Market cap
$0
P/E (TTM)
-6.75
EPS (TTM)
$-0.47
Beta
-0.33
50-day avg
$2.76
200-day avg
$2.78
52-week high
$9.01
52-week low
$1.34

ETFs linked to RCOR

Broad-market and Healthcare sector ETFs an investor holding Renovacor is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how RCOR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze RCOR in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Renovacor?
Renovacor trades under the ticker RCOR on AMEX.
Which exchange is RCOR listed on?
RCOR is listed on AMEX.
What sector does Renovacor operate in?
Renovacor is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze RCOR in a portfolio?
PortView shows RCOR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.